Egis Pharmaceuticals named the most attractive employer in the life sciences sector
Mon, May 11, 2026 3:20 PM
The life sciences sector is increasingly gaining ground among the most popular employer sectors among employees, and this year Egis Pharmaceuticals PLC earned the recognition awarded to the most attractive workplaces in Randstad’s employer brand research, outperforming renowned peers from Hungary and multinational backgrounds. More

Capacity expansion investments are ongoing in Körmend

On 23 March 2026, Péter Szijjártó, Minister of Foreign Affairs and Trade, and István Joó, CEO of the Hungarian Investment Promotion Agency (HIPA), visited the Körmend site of Egis Pharmaceuticals
Mar. 23.
More

Egis receives the Top Employer 2026 recognition

Egis Pharmaceuticals Plc. once again received the Top Employer Hungary certification in 2026, which is the result of an assessment based on an independent, international methodology.
Jan. 15.
More

Dennis Gábor Award: Two laureates’ achievements are linked to Egis

For his outstanding innovation activities, Dr. Balázs Volk, Director of Drug Substance Development at Egis, received the Dennis Gábor Award, while Dr. Pál Fekete, retired Head of Pharmaceutical Technology Operations, was honored with the Dennis Gábor Lifetime Achievement Award. The award serves as a heightened moral recognition for Hungarian professionals who play a creative role in the innovation process and pursue exceptional scientific and R&D activities. Considering all fields of science, only about seven nominated individuals receive this honor each year. The fact that among the awardees we can celebrate both an active and a retired colleague demonstrates the high quality of scientific work and advanced innovation capabilities at Egis.
Dec. 16.
More
Aug. 26.

Change in the management of the Commercial Directorate

After sixteen years with the company, Dr Péter Mázsár, Commercial Director will leave Egis at the end of August.

More
Jul. 15.

Good results for Egis sailing boats in the Blue Ribbon race

On 14 July, more than 2,500 crew members on 516 boats set sail, taking part in the traditional Blue Ribbon regatta, in which the sailing section of Egis also successfully tackled the more than 150 km route around the lake.

More
Jul. 05.

Csaba Poroszlai is CEO of Egis Pharmaceuticals PLC

Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.

More
Jun. 27.

Dr István Hodász, former CEO of Egis becomes honorary citizen of Kőbánya

The recognition can be bestowed on a person who - through their activities, work, and attitude - has contributed to the development and growth of the district and thus raised the reputation of Kőbánya.

More
Jun. 22.

Young inventor receives Egis award

In the 2021/2022 school year, the Hungarian Association for Innovation launched its competition for secondary school students for the 31st time. The Association recognized not only young innovators, but the most successful innovative schools and exceptionally innovative secondary school teachers were awarded too. Our company has been supporting the Scientific and Innovation Talent Recruitment Contest for Youth for decades.

More
Jun. 17.

Egis announces further investments at its Körmend site

Over the next few years, Egis Pharmaceuticals PLC will invest EUR 21.1 million to increase its capacity at its Körmend site. To finance these developments, Egis will use its own capital and a government subsidy of EUR 3.4 million – announced Csaba Poroszlai, CEO of Egis. In total, the company will devote more than EUR 50 million to the development of the Körmend site of Egis since 2019.

More
Jun. 14.

Night of Museums - first time at Egis

The Egis Science and Technology Centre welcomes visitors on the longest night of the year

More
Jun. 14.

A unique chemistry competition sponsored by Egis

Although the Researchers' Night will not take place until autumn, one of the side events of the large-scale event is already open for registration: the thought-provoking chemistry competition is sponsored by Egis.

More
May. 20.

Csaba Poroszlai elected vice president of MAGYOSZ

Mr. Csaba Poroszlai, CEO of Egis and dr Tamás Rónay CEO of Sanofi-Aventis and Chinoin were elected vice presidents of the Hungarian Pharmaceutical Manufacturers’ Association (MAGYOSZ) at the Association’s annual general meeting. The executive director of Meditop Kft., dr Dávid Greskovits, will hold the position of president for another three years. Mr. Csaba Poroszlai has also become the member of the presidential board.

More
May. 12.

Egis hosted jobseekers in five job fairs

There were five opportunities to meet us this spring.

More
May. 04.

Egis sponsored the 40th Hungarian Press Photo Contest

The Hungarian Press Photo Contest, the most prestigious national competition for photographers and news photographers in Hungary was held for the 40th times. Once again, Egis sponsored the Nature and science category of the contest. Many of the submitted photos are on display in the Hungarian National Museum in Budapest, however, the exhibition will later travel to other locations in the country as well.

More
Apr. 22.

Egis wins UNICEO award for its series of “Theme-based months”

Egis’ theme-based program series was recognized by UNICEO (United Networks of International Corporate Event Organizers), the company’s initiative won a “Live Communication” 2021 award as “Best online event for employees”.

More

Submit
Submit

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox